Zheng Cui, Xiachang Wang1, Stefan Koppermann2, Jon S Thorson, Christian Ducho2, Steven G Van Lanen. 1. Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, School of Pharmacy , Nanjing University of Chinese Medicine , Nanjing 210023 , People's Republic of China. 2. Department of Pharmacy, Pharmaceutical and Medicinal Chemistry , Saarland University Campus C2 3 , 66123 Saarbrücken , Germany.
Abstract
Muraymycins are nucleoside antibiotics isolated from Streptomyces sp. NRRL 30471 and several mutant strains thereof that were generated by random, chemical mutagenesis. Reinvestigation of two mutant strains using new media conditions led to the isolation of three new muraymycin congeners, named B8, B9, and C6 (1-3), as well as a known muraymycin, C1. Structures of the compounds were elucidated by HRMS and 1D and 2D NMR spectroscopic analyses. Complete 2D NMR assignments for the known muraymycin C1 are also provided for the first time. Compounds 1 and 2, which differ from other muraymycins by having an elongated, terminally branched fatty acid side chain, had picomolar IC50 values against Staphylococcus aureus and Aquifex aeolicus MraY and showed good antibacterial activity against S. aureus (MIC = 2 and 6 μg/mL, respectively) and Escherichia coli Δ tolC (MIC = 4 and 2 μg/mL, respectively). Compound 3, which is characterized by an N-acetyl modification of the primary amine of the dissacharide core that is shared among nearly all of the reported muraymycin congeners, greatly reduced its inhibitory and antibacterial activity compared to nonacylated muraymycin C1, which possibly indicates this modification is used for self-resistance.
Muraymycins are n class="Chemical">nucleoside antibiotics isolated from Streptomyces sp. NRRL 30471 and several mutant strains thereof that were generated by random, chemical mutagenesis. Reinvestigation of two mutant strains using new media conditions led to the isolation of three new muraymycin congeners, named B8, B9, and C6 (1-3), as well as a known muraymycin, C1. Structures of the compounds were elucidated by HRMS and 1D and 2D NMR spectroscopic analyses. Complete 2D NMR assignments for the known muraymycin C1 are also provided for the first time. Compounds 1 and 2, which differ from other muraymycins by having an elongated, terminally branched fatty acid side chain, had picomolar IC50 values against Staphylococcus aureus and Aquifex aeolicus MraY and showed good antibacterial activity against S. aureus (MIC = 2 and 6 μg/mL, respectively) and Escherichia coli Δ tolC (MIC = 4 and 2 μg/mL, respectively). Compound 3, which is characterized by an N-acetyl modification of the primary amine of the dissacharide core that is shared among nearly all of the reported muraymycin congeners, greatly reduced its inhibitory and antibacterial activity compared to nonacylated muraymycin C1, which possibly indicates this modification is used for self-resistance.
Authors: Thérèse Stachyra; Christophe Dini; Paul Ferrari; Ahmed Bouhss; Jean van Heijenoort; Dominique Mengin-Lecreulx; Didier Blanot; Jacques Biton; Dominique Le Beller Journal: Antimicrob Agents Chemother Date: 2004-03 Impact factor: 5.191
Authors: Stefan Koppermann; Zheng Cui; Patrick D Fischer; Xiachang Wang; Jannine Ludwig; Jon S Thorson; Steven G Van Lanen; Christian Ducho Journal: ChemMedChem Date: 2018-03-23 Impact factor: 3.466
Authors: P E Brandish; K I Kimura; M Inukai; R Southgate; J T Lonsdale; T D Bugg Journal: Antimicrob Agents Chemother Date: 1996-07 Impact factor: 5.191
Authors: Maria T Rodolis; Agnes Mihalyi; Christian Ducho; Kornelia Eitel; Bertolt Gust; Rebecca J M Goss; Timothy D H Bugg Journal: Chem Commun (Camb) Date: 2014-11-07 Impact factor: 6.222
Authors: Leonard A McDonald; Laurel R Barbieri; Guy T Carter; Eileen Lenoy; Jason Lotvin; Peter J Petersen; Marshall M Siegel; Guy Singh; R Thomas Williamson Journal: J Am Chem Soc Date: 2002-09-04 Impact factor: 15.419
Authors: Zheng Cui; Xia-Chang Wang; Xiaodong Liu; Anke Lemke; Stefan Koppermann; Christian Ducho; Jürgen Rohr; Jon S Thorson; Steven G Van Lanen Journal: Antimicrob Agents Chemother Date: 2018-06-26 Impact factor: 5.191
Authors: Zheng Cui; Xiaodong Liu; Jonathan Overbay; Wenlong Cai; Xiachang Wang; Anke Lemke; Daniel Wiegmann; Giuliana Niro; Jon S Thorson; Christian Ducho; Steven G Van Lanen Journal: J Org Chem Date: 2018-05-24 Impact factor: 4.354